Myelodysplastic syndromes are propagated by rare and distinct human cancer stem cells in vivo
Evidence for distinct human cancer stem cells (CSCs) remains contentious and the degree to which differentcancer cells contribute to propagating malignancies in patients remains unexplored. In low- to intermediate-risk myelodysplastic syndromes (MDS), we establish the existence of rare multipotent M...
Main Authors: | Woll, P, Kjällquist, U, Chowdhury, O, Doolittle, H, Wedge, D, Thongjuea, S, Erlandsson, R, Ngara, M, Anderson, K, Deng, Q, Mead, A, Stenson, L, Giustacchini, A, Duarte, S, Giannoulatou, E, Taylor, S, Karimi, M, Scharenberg, C, Mortera-Blanco, T, Macaulay, I, Clark, S, Dybedal, I, Josefsen, D, Fenaux, P, Hokland, P |
---|---|
Format: | Journal article |
Language: | English |
Published: |
Cell Press
2014
|
Similar Items
-
Erratum to Myelodysplastic syndromes are propagated by rare and distinct human cancer stem cells in vivo [Cancer Cell, 25 (2014) 794-808]
by: Woll, P, et al.
Published: (2014) -
Myelodysplastic syndromes are propagated by rare and distinct human cancer stem cells in vivo.
by: Woll, P, et al.
Published: (2014) -
Perturbed hematopoietic stem and progenitor cell hierarchy in myelodysplastic syndromes patients with monosomy 7 as the sole cytogenetic abnormality.
by: Dimitriou, M, et al.
Published: (2016) -
Progression in patients with low- and intermediate1-risk del(5q) myelodysplastic syndromes is predicted by a limited subset of mutations.
by: Scharenberg, C, et al.
Published: (2016) -
The role and impact of Del(5q) and TP53 mutations on haematopoietic stem and progenitor cells during the progression of Myelodysplastic Syndrome to Acute Myeloid Leukaemia
by: Doolittle, H
Published: (2017)